A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper‐64 with High Tumor Uptake and Retention-Reference-Cited by-同舟云学术

A Bivalent Inhibitor of Prostate Specific Membrane Antigen Radiolabeled with Copper‐64 with High Tumor Uptake and Retention

Published:2019-09-05 Issue:42 Volume:58 Page:14991-14994
ISSN:1433-7851
Container-title:Angewandte Chemie International Edition
language:en
Short-container-title:Angew. Chem. Int. Ed.

Author:

Zia Nicholas A.¹,Cullinane Carleen²³^ORCID,Van Zuylekom Jessica K.³,Waldeck Kelly³^ORCID,McInnes Lachlan E.¹,Buncic Gojko¹,Haskali Mohammad B.⁴^ORCID,Roselt Peter D.⁴^ORCID,Hicks Rodney J.²³⁴^ORCID,Donnelly Paul S.¹^ORCID

Affiliation:

1. School of Chemistry and Bio21 Molecular Science and Biotechnology Institute University of Melbourne Melbourne 3010 Vic. Australia

2. Sir Peter MacCallum Department of Oncology University of Melbourne Melbourne 3010 Vic. Australia

3. Research Division Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia

4. Centre for Cancer Imaging Peter MacCallum Cancer Centre Melbourne Victoria 3000 Australia

Funder

National Health and Medical Research Council

Australian Research Council

Publisher

Wiley

Subject

General Chemistry,Catalysis

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/anie.201908964

Reference49 articles.

1. The Rise of PSMA Ligands for Diagnosis and Therapy of Prostate Cancer

3. Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase

4. Isolation and Expression of Novel Human Glutamate Carboxypeptidases with N-Acetylated α-Linked Acidic Dipeptidase and Dipeptidyl Peptidase IV Activity

5. NAAG peptidase inhibitors and their potential for diagnosis and therapy

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ⁶¹Cu-PSMA–Targeted PET for Prostate Cancer: From Radiotracer Development to First-in-Human Imaging;Journal of Nuclear Medicine;2024-07-18

2. Copper and Copper Complexes in Tumor Therapy;ChemMedChem;2024-03-22

3. 64Cu production via the 68Zn(p,nα)64Cu nuclear reaction: An untapped, cost-effective and high energy production route;Nuclear Medicine and Biology;2024-01

4. ¹⁷⁷Lu-Labeled Bivalent Ligands of Prostate-Specific Membrane Antigen for Endoradiotherapy of Prostate Cancer;Molecular Pharmaceutics;2023-12-28

5. Design, synthesis, and biological evaluation of novel bivalent PI3K inhibitors for the potential treatment of cancer;Bioorganic Chemistry;2023-11